Submitted by Anonymous (not verified) on 26 October 2023 - 9:38
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 10, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Piqray, alpelisib, Breast Neoplasms, Date of authorisation: 27/07/2020, Revision: 10, Status: Authorised